Steriale is a Spanish tech-health company that has developed solutions for the management of hospital biological-infectious waste (RBI). The company, through its patents and know-how, has created various products and services patented globally. Their focus is on ensuring the safety of the medical center's temporary personnel, patients, and external personnel (such as visitors and suppliers). Additionally, they have carefully considered the duration for which contaminated waste remains potentially infectious in the generating center, during transport, and in final disposal. The company promotes the immediate and on-site elimination of such waste. Furthermore, environmental conservation is a key consideration for Steriale. The waste is deposited in cardboard and paper materials, as opposed to the current practice of using plastic containers and bags that are either incinerated or end up in a sanitary landfill, where decomposition takes a considerable time. The company operates in the healthcare and medical devices industries. With no specific information available regarding the founding date, headquarter location, or recent investments, it creates an opportunity for potential investors seeking to support innovative solutions within the healthcare industry. Steriale's approach to handling biohazardous waste aligns with the increasing global emphasis on sustainable and eco-friendly practices, appealing to the socially responsible investor.
There is no investment information
No recent news or press coverage available for Steriale.